Apotea AB (V30)
XDUS
8.04
+0.05 (+0.69%)
Delayed Data
Oct 16, 2026, 06:00 AM
Day's Range
8.008.16
52 wk Range
5.078.60
Financial Statements - V30 - Apotea AB
Revenue
7.20B▲ 10.1%
Net Income
226.30M▲ 6.7%Net Margin 3.1%
EBITDA
470.30M▲ 17.7%
Free Cash Flow
117.70M▲ 177.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Sales | 7.20B | 6.54B | 5.45B | 4.88B | 4.57B |
| Cost of Goods | 5.26B | 4.75B | 4B | 3.61B | 3.38B |
| Gross Profit | 1.93B | 1.78B | 1.44B | 1.27B | 1.19B |
 Operating Expense | - | - | - | - | - |
| Operating Income | 303.70M | 262.80M | 113.40M | 49M | 134.40M |
| Non-Operating Interest | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - |
| Pre Tax Income | 289.80M | 264.70M | 108.70M | 31M | 130.90M |
| Income Tax | 63.50M | 52.70M | 26.40M | 12.70M | 26M |
| Net Income | 226.30M | 212M | 82.40M | 18.30M | 104.90M |
| EPS Basic | 2.2 | 2.09 | 0.835968 | 0.191216 | 1.007966 |
| EPS Diluted | 2.2 | 2.09 | 0.835968 | 0.191216 | 1.007966 |
| Basic Shares Outstanding | 104.07M | 102.55M | 1.13B | 1.13B | 1.16B |
| Diluted Shares Outstanding | 104.07M | 102.55M | 1.13B | 1.13B | 1.16B |
| Ebit | 301.80M | 270M | 115M | 34.80M | 134.30M |
| Ebitda | 470.30M | 399.60M | 227.70M | 118.50M | 184.20M |
| Net Income Continuous Operations | 298.20M | 265.80M | 113.60M | 48.30M | 134.10M |
| Minority Interests | 2.40M | 2.90M | 4.70M | 1.60M | 0 |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
